David M. Briscoe

6.4k total citations · 1 hit paper
112 papers, 5.1k citations indexed

About

David M. Briscoe is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, David M. Briscoe has authored 112 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 32 papers in Surgery and 32 papers in Immunology. Recurrent topics in David M. Briscoe's work include Transplantation: Methods and Outcomes (23 papers), Angiogenesis and VEGF in Cancer (23 papers) and Cell Adhesion Molecules Research (20 papers). David M. Briscoe is often cited by papers focused on Transplantation: Methods and Outcomes (23 papers), Angiogenesis and VEGF in Cancer (23 papers) and Cell Adhesion Molecules Research (20 papers). David M. Briscoe collaborates with scholars based in United States, Germany and France. David M. Briscoe's co-authors include Marlies E. J. Reinders, Christopher Geehan, Soumitro Pal, J S Pober, Peter Ganz, Dipak Datta, R. S. Cotran, Olivier Dormond, Michael Melter and Mark Denton and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

David M. Briscoe

112 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

2013 501 citations David M. Briscoe et al. profile →

Peers

Countries citing papers authored by David M. Briscoe

Since Specialization

Citations

This map shows the geographic impact of David M. Briscoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Briscoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Briscoe more than expected).

Fields of papers citing papers by David M. Briscoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Briscoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Briscoe. The network helps show where David M. Briscoe may publish in the future.

Co-authorship network of co-authors of David M. Briscoe

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Briscoe. A scholar is included among the top collaborators of David M. Briscoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Briscoe. David M. Briscoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology 2023 ·Population Health Management ·Harvey W. Kaufman, William A. Meyer, Nigel J. Clarke, Jeff Radcliff, Christopher M. Rank, James Freeman, Marcia Eisenberg, (unknown), William G. Morice, David M. Briscoe, David S. Perlin, Jay G. Wohlgemuth	4
2	Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4+ T cells 2021 ·American Journal of Transplantation ·Timna Agur, Johannes Wedel, Sayantan Bose, (unknown), Daniel B. Goodman, Sek Won Kong, Chandra C. Ghosh, David M. Briscoe	6
3	Convergent and Divergent Migratory Patterns of Human Neutrophils inside Microfluidic Mazes 2018 ·Scientific Reports ·Leo Boneschansker, Julianne Jorgensen, Felix Ellett, David M. Briscoe, Daniel Irimia	15
4	Vegf-A Predicts the Development of Moderate or Severe Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients 2014 ·Transplantation ·Kevin P. Daly, (unknown), Michele F. Eisenga, (unknown), David Zurakowski, Elizabeth D. Blume, David M. Briscoe	2
5	Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation 2012 ·Frontiers in Immunology ·Sarah Bruneau, Craig B. Woda, Kevin P. Daly, (unknown), Namrata G. Jain, (unknown), Alan G. Contreras, Tatsuichiro Seto, David M. Briscoe	34
6	Subsets of human CD4⁺ regulatory T cells express the peripheral homing receptor CXCR3 2011 ·European Journal of Immunology ·André Hoerning, (unknown), Dipak Datta, (unknown), Caroline N. Jones, Ian Y. Wong, Daniel Irimia, (unknown), (unknown), Peter F. Hoyer, William Harmon, David M. Briscoe	61
7	Calcineurin Inhibitors Activate the Proto-Oncogene Ras and Promote Protumorigenic Signals in Renal Cancer Cells 2009 ·Cancer Research ·Dipak Datta, Alan G. Contreras, Aninda Basu, Olivier Dormond, Evelyn Flynn, David M. Briscoe, Soumitro Pal	54
8	Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer 2008 ·Cancer Research ·Aninda Basu, Alan G. Contreras, Dipak Datta, Evelyn Flynn, Liling Zeng, Herbert T. Cohen, David M. Briscoe, Soumitro Pal	56
9	CD40-Induced Signaling in Human Endothelial Cells Results in mTORC2- and Akt-Dependent Expression of Vascular Endothelial Growth Factor In Vitro and In Vivo 2008 ·The Journal of Immunology ·Olivier Dormond, Alan G. Contreras, Esther Meijer, Dipak Datta, Evelyn Flynn, Soumitro Pal, David M. Briscoe	44
10	Ras-induced Modulation of CXCL10 and Its Receptor Splice Variant CXCR3-B in MDA-MB-435 and MCF-7 Cells: Relevance for the Development of Human Breast Cancer 2006 ·Cancer Research ·Dipak Datta, (unknown), (unknown), Christopher Geehan, Martin Grimm, Ana Maria Waaga-Gasser, David M. Briscoe, Soumitro Pal	142
11	Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. 2006 ·Cancer Research ·Thuy L. Phung, Carole Perruzzi, Rita A. Monahan-Earley, Janice A. Nagy, David M. Briscoe, Kenneth Walsh, William C. Sessa, Ann M. Dvořàk, Harold F. Dvorak, Laura E. Benjamin	6
12	Vascular Endothelial Growth Factor-Induced Signaling Pathways in Endothelial Cells That Mediate Overexpression of the Chemokine IFN-γ-Inducible Protein of 10 kDa In Vitro and In Vivo 2006 ·The Journal of Immunology ·Gwénola Boulday, Zdenka Hašková, Marlies E. J. Reinders, Soumitro Pal, David M. Briscoe	59
13	Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin 2006 ·Cancer Cell ·Thuy L. Phung, Keren Ziv, Donnette Dabydeen, (unknown), Marcela Riveros, Carole Perruzzi, Jingfang Sun, Rita A. Monahan-Earley, Ichiro Shiojima, Janice A. Nagy, Michelle I. Lin, Kenneth Walsh, Ann M. Dvořàk, David M. Briscoe, Michal Neeman, William C. Sessa, Harold F. Dvorak, Laura E. Benjamin	356
14	The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase 2004 ·The Journal of Immunology ·(unknown), Michael Melter, Peter H. Lapchak, David M. Briscoe, Soumitro Pal	47
15	TNP-470, an Angiogenesis Inhibitor, Attenuates the Development of Allograft Vasculopathy 2004 ·Transplantation ·Mark Denton, Colm Magee, Michael Melter, Vikas R. Dharnidharka, Mohamed H. Sayegh, David M. Briscoe	12
16	Proangiogenic Function of CD40 Ligand-CD40 Interactions 2003 ·The Journal of Immunology ·Marlies E. J. Reinders, Masayuki Sho, (unknown), Christopher Geehan, David M. Briscoe	63
17	Endothelial injury: cause and effect of alloimmune inflammation 2002 ·Transplant Infectious Disease ·Ingrid H. C. Vos, David M. Briscoe	18
18	Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro 2001 ·The Journal of Immunology ·Markus H. Frank, Mark Denton, Stephen I. Alexander, Samia J. Khoury, Mohamed H. Sayegh, David M. Briscoe	61
19	Prdictive Value Of Inducible Endothelial Cell Adhesion Molecule Expression For Acte Rejection Of Human Cardiac Allografts 1995 ·Transplantation ·David M. Briscoe, Alan C. Yeung, (unknown), Elizabeth N. Allred, George Stavrakis, Peter Ganz, R. S. Cotran, J S Pober	93
20	Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. 1991 ·PubMed ·David M. Briscoe, Frederick J. Schoen, Gregory E. Rice, M P Bevilacqua, Peter Ganz, J S Pober	111

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact